UBS OCONNOR LLC - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is and the CUSIP is 74365AAD3. A total of 7 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS OCONNOR LLC ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2021$7,840,000,0000.0%8,000,0000.0%0.07%
-38.1%
Q1 2021$7,840,000,000
+5.4%
8,000,0000.0%0.11%
-25.7%
Q4 2020$7,440,000,000
+3.3%
8,000,0000.0%0.15%
-16.9%
Q3 2020$7,200,000,0000.0%8,000,0000.0%0.18%
+15.1%
Q2 2020$7,200,000,0000.0%8,000,0000.0%0.16%
+7.4%
Q1 2020$7,200,000,000
+1.1%
8,000,0000.0%0.15%
-26.4%
Q4 2019$7,120,000,000
-6.7%
8,000,0000.0%0.20%
-5.2%
Q3 2019$7,628,000,0000.0%8,000,0000.0%0.21%
+43.2%
Q2 2019$7,628,000,000
+3.6%
8,000,0000.0%0.15%
-44.2%
Q4 2018$7,360,000,000
-3.4%
8,000,0000.0%0.26%
+51.4%
Q3 2018$7,620,000,000
+5.8%
8,000,0000.0%0.18%
+21.5%
Q2 2018$7,200,000,000
+5.6%
8,000,000
+14.3%
0.14%
+9.9%
Q1 2018$6,816,000,000
-21.1%
7,000,000
-22.2%
0.13%
-14.4%
Q4 2017$8,638,000,000
+169.9%
9,000,000
+125.0%
0.15%
+225.5%
Q3 2017$3,200,000,000
-39.2%
4,000,000
-39.2%
0.05%
-45.3%
Q2 2017$5,263,000,000
-12.6%
6,579,000
-12.6%
0.09%
-15.7%
Q1 2017$6,020,000,000
-13.5%
7,525,000
-11.7%
0.10%
-23.9%
Q4 2016$6,956,000,0008,525,0000.13%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
HIGHBRIDGE CAPITAL MANAGEMENT LLC 31,014,000$29,401,0001.13%
UBS OCONNOR LLC 8,000,000$7,440,000,0000.15%
WHITEBOX ADVISORS LLC 5,000,000$4,727,0000.15%
ANGELO GORDON & CO., L.P. 1,397,000$1,321,0000.12%
INGALLS & SNYDER LLC 500,000$474,0000.02%
CITIGROUP INC 7,832,000$7,404,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders